These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid. Daley-Yates PT, McBrien DC. Biochem Pharmacol; 1982 Jul 01; 31(13):2243-6. PubMed ID: 6889863 [Abstract] [Full Text] [Related]
3. A study of the protective effect of chloride salts on cisplatin nephrotoxicity. Daley-Yates PT, McBrien DC. Biochem Pharmacol; 1985 Jul 01; 34(13):2363-9. PubMed ID: 4040367 [Abstract] [Full Text] [Related]
4. Cisplatin nephrotoxicity: role of filtration and tubular transport of cisplatin in isolated perfused kidneys. Miura K, Goldstein RS, Pasino DA, Hook JB. Toxicology; 1987 May 01; 44(2):147-58. PubMed ID: 3564050 [Abstract] [Full Text] [Related]
6. Mechanism of cisplatin nephrotoxicity. Weiner MW, Jacobs C. Fed Proc; 1983 Oct 01; 42(13):2974-8. PubMed ID: 6684595 [Abstract] [Full Text] [Related]
7. Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum. Dumas M, de Gislain C, d'Athis P, Chadoint-Noudeau V, Escousse A, Guerrin J, Autissier N. Cancer Chemother Pharmacol; 1989 Oct 01; 23(1):37-40. PubMed ID: 2909288 [Abstract] [Full Text] [Related]
9. The relative nephrotoxicity of cisplatin, cis-[Pt(NH3)2(guanosine)2]2+, and the hydrolysis product of cisplatin in the rat. Jones MM, Basinger MA, Beaty JA, Holscher MA. Cancer Chemother Pharmacol; 1991 Oct 01; 29(1):29-32. PubMed ID: 1742846 [Abstract] [Full Text] [Related]
10. Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats. Wolfgang GH, Dominick MA, Walsh KM, Hoeschele JD, Pegg DG. Fundam Appl Toxicol; 1994 Jan 01; 22(1):73-9. PubMed ID: 8125216 [Abstract] [Full Text] [Related]
11. The effect of sodium thiosulfate on subcellular localization of platinum in rat kidney after treatment with cisplatin. Uozumi J, Litterst CL. Cancer Lett; 1986 Sep 01; 32(3):279-83. PubMed ID: 3768854 [Abstract] [Full Text] [Related]
12. [Platinum agent-induced nephrotoxicity via organic cation transport system]. Yonezawa A. Yakugaku Zasshi; 2012 Sep 01; 132(11):1281-5. PubMed ID: 23123720 [Abstract] [Full Text] [Related]
13. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats. Yasumasu T, Ueda T, Uozumi J, Mihara Y, Kumazawa J. Pharmacol Toxicol; 1992 Feb 01; 70(2):143-7. PubMed ID: 1508841 [Abstract] [Full Text] [Related]
14. Protective effect of organic cation transport inhibitors on cis-diamminedichloroplatinum-induced nephrotoxicity. Bird JE, Walser MM, Quebbemann AJ. J Pharmacol Exp Ther; 1984 Dec 01; 231(3):752-8. PubMed ID: 6542140 [Abstract] [Full Text] [Related]
15. Minireview. The nephrotoxicity of cisplatin. Goldstein RS, Mayor GH. Life Sci; 1983 Feb 14; 32(7):685-90. PubMed ID: 6338333 [Abstract] [Full Text] [Related]
16. Cisplatin nephrotoxicity: insights into mechanism. Safirstein R, Winston J, Moel D, Dikman S, Guttenplan J. Int J Androl; 1987 Feb 14; 10(1):325-46. PubMed ID: 3583421 [Abstract] [Full Text] [Related]
17. Intracellular metabolites of cisplatin in the rat kidney. Mistry P, Lee C, McBrien DC. Cancer Chemother Pharmacol; 1989 Feb 14; 24(2):73-9. PubMed ID: 2731314 [Abstract] [Full Text] [Related]
18. Collecting duct function in cis-platinum nephrotoxicity. Wilson DR, Honrath U. Can J Physiol Pharmacol; 1987 Jun 14; 65(6):1200-4. PubMed ID: 3621067 [Abstract] [Full Text] [Related]
19. Uptake and metabolism of cisplatin by rat kidney. Safirstein R, Miller P, Guttenplan JB. Kidney Int; 1984 May 14; 25(5):753-8. PubMed ID: 6540826 [Abstract] [Full Text] [Related]